# FDA Inspection 1328024 - Mirum Pharmaceuticals, Inc. - July 24, 2026

Source: https://www.keypedia.com/records/fda_inspections/mirum-pharmaceuticals-inc/e9d59fb4-c972-4887-b533-d10fdca95bc0
Source feed: FDA_Inspections

> FDA Inspection 1328024 for Mirum Pharmaceuticals, Inc. on July 24, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1328024
- Company Name: Mirum Pharmaceuticals, Inc.
- Inspection Date: 2026-07-24
- Project Area: Postmarket Surv. and Epidemiology
- Product Type: Human Drugs
- Office Name: San Francisco District Office

## Related Documents

- [FDA Inspection 1259153 - 2024-12-05](https://www.keypedia.com/records/fda_inspections/mirum-pharmaceuticals-inc/6e651f6b-bf5a-442a-a9e3-52671438a5ec)
- [FDA Inspection 1259153 - 2024-12-05](https://www.keypedia.com/records/fda_inspections/mirum-pharmaceuticals-inc/62d07b12-1f93-429a-b15b-c2c2460ae595)
- [FDA Inspection 1220683 - 2023-10-03](https://www.keypedia.com/records/fda_inspections/mirum-pharmaceuticals-inc/d318e671-4bc3-4e71-afb8-2dec8ab97c9b)
- [FDA Inspection 1142794 - 2021-05-12](https://www.keypedia.com/records/fda_inspections/mirum-pharmaceuticals-inc/bfdc931b-8231-4a10-a274-0a50f91766e7)

Company: https://www.keypedia.com/companies/mirum-pharmaceuticals-inc/9b906e94-ef88-467f-8b15-9f0b02d9e49d

Office: https://www.keypedia.com/offices/san-francisco-district-office/6f838e9c-aae1-4665-9c46-a51d43be02df